MYD88 and neoplasm: In regard to the detection sensitivity of MYD88 L265P mutation, it has been previously reported that although lower BM burden (<10% infiltrate) in patients could result to false negative results, AS-PCR is sensitive enough to detect the L265P mutation in tumor cells as low as 1.25% [35].